Literature DB >> 19655349

Enantioselective total synthesis of brevetoxin A: convergent coupling strategy and completion.

Michael T Crimmins1, J Lucas Zuccarello, Patrick J McDougall, J Michael Ellis.   

Abstract

A highly convergent, enantioselective total synthesis of brevetoxin A is reported. The development of a [X+2+X] Horner-Wadsworth-Emmons/cyclodehydration/reductive etherification convergent coupling strategy allowed a unified approach to the synthesis of two advanced tetracyclic fragments from four cyclic ether subunits. The Horner-Wittig coupling of the two tetracyclic fragments provided substrates that were explored for reductive etherification, the success of which delivered a late-stage tetraol intermediate. The tetraol was converted to the natural product through an expeditious selective oxidative process followed by methylenation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19655349      PMCID: PMC2826122          DOI: 10.1002/chem.200900777

Source DB:  PubMed          Journal:  Chemistry        ISSN: 0947-6539            Impact factor:   5.236


  16 in total

Review 1.  New efficient iterative approaches to polycyclic ethers.

Authors:  Fredrik P Marmsäter; Frederick G West
Journal:  Chemistry       Date:  2002-10-04       Impact factor: 5.236

2.  A convergent coupling strategy for the formation of polycyclic ethers: stereoselective synthesis of the BCDE fragment of brevetoxin A.

Authors:  Michael T Crimmins; Patrick J McDougall; Kyle A Emmitte
Journal:  Org Lett       Date:  2005-09-01       Impact factor: 6.005

3.  The total synthesis of gambierol.

Authors:  Henry W B Johnson; Utpal Majumder; Jon D Rainier
Journal:  J Am Chem Soc       Date:  2005-01-26       Impact factor: 15.419

4.  Synthetic studies on the bryostatins: preparation of a truncated BC-ring intermediate by pyran annulation.

Authors:  Gary E Keck; Anh P Truong
Journal:  Org Lett       Date:  2005-05-26       Impact factor: 6.005

5.  Convergent, stereoselective synthesis of the GHIJ fragment of brevetoxin A.

Authors:  Michael T Crimmins; J Lucas Zuccarello; Pamela A Cleary; Jonathan D Parrish
Journal:  Org Lett       Date:  2006-01-05       Impact factor: 6.005

Review 6.  Total synthesis of marine polycyclic ethers.

Authors:  Tadashi Nakata
Journal:  Chem Rev       Date:  2005-12       Impact factor: 60.622

Review 7.  Convergent strategies for syntheses of trans-fused polycyclic ethers.

Authors:  Masayuki Inoue
Journal:  Chem Rev       Date:  2005-12       Impact factor: 60.622

8.  Improved synthesis of the ABCDE fragment of brevetoxin A.

Authors:  Michael T Crimmins; Patrick J McDougall; J Michael Ellis
Journal:  Org Lett       Date:  2006-08-31       Impact factor: 6.005

9.  Synthetic strategies of marine polycyclic ethers via intramolecular allylations: linear and convergent approaches.

Authors:  Isao Kadota; Yoshinori Yamamoto
Journal:  Acc Chem Res       Date:  2005-05       Impact factor: 22.384

10.  Enantioselective total synthesis of brevetoxin A: unified strategy for the B, E, G, and J subunits.

Authors:  Michael T Crimmins; J Michael Ellis; Kyle A Emmitte; Pamela A Haile; Patrick J McDougall; Jonathan D Parrish; J Lucas Zuccarello
Journal:  Chemistry       Date:  2009-09-14       Impact factor: 5.236

View more
  3 in total

Review 1.  Constructing molecular complexity and diversity: total synthesis of natural products of biological and medicinal importance.

Authors:  K C Nicolaou; Christopher R H Hale; Christian Nilewski; Heraklidia A Ioannidou
Journal:  Chem Soc Rev       Date:  2012-06-28       Impact factor: 54.564

2.  Maitotoxin: An Inspiration for Synthesis.

Authors:  K C Nicolaou; Robert J Aversa
Journal:  Isr J Chem       Date:  2011-04       Impact factor: 3.333

3.  Enantioselective total synthesis of brevetoxin A: unified strategy for the B, E, G, and J subunits.

Authors:  Michael T Crimmins; J Michael Ellis; Kyle A Emmitte; Pamela A Haile; Patrick J McDougall; Jonathan D Parrish; J Lucas Zuccarello
Journal:  Chemistry       Date:  2009-09-14       Impact factor: 5.236

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.